ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,515, issued on Feb. 18, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.) and University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh).
"In-flow photooxygenation of aminothienopyridinones generates novel PTP4A3 phosphatase inhibitors" was invented by John S. Lazo (Charlottesville, Va.), Elizabeth Sharlow (Butler, Pa.), Peter Wipf (Pittsburgh), Nikhil Tasker (Trumbull, Conn.) and Ettore Rastelli (Pittsburgh).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compounds that inhibit protein tyrosine phosphatase, such as protein tyrosine phosphatase 4 A3 (PTP4A3). The disclosur...